Iran’s success in controlling Covid-19 outbreak
Authors: Nima Mohammadzadeh, Mahla Shahriary
Coronavirus disease 2019 (COVID-19) ) is a respiratory tract infection ranging from mild respiratory illness (respiratory symptoms, cough, fever, shortness of breath and breathing difficulties) to severe ones (pneumonia, severe acute respiratory syndrome, kidney failure and death) that caused one of the most unprecedented global crises in less than 90 days in all 206 countries around the world . Today, most of the world’s major cities are in full quarantine and all social and economic behaviors have been limited due to outbreak of the virus. Controlling the spread of the virus has become one of the most important challenges for governments in the world. Looking at the growth of the virus in the advanced industrial countries, including Italy, Germany, France, Spain, and United States of America reflects the rapid progress of this infectious disease. To date (4 April 2020), Italy with almost 60 million populations by having around 119827 patients (Case Fatality Rate (CFR) 12.25 %), Germany with almost 82 million populations by having around 85778 patients (CFR 1.34 %), France with almost 66 million by having around 63536 patients (CFR 10.21 %), Spain with almost 46 million people by having around 117710 patients (CFR 9.28 %), and USA with 320 million populations by having 241703 patients (CFR 2.42 %) are among the mostly affected countries. The prevalence of the virus is rapidly increasing. Iran, with a population of almost 81 million, has an estimated stricken people of 44605 and 2898 deaths (diagram 1) . Although Iran has been heavily sanctioned in all fields of industry and pharmacy, it has been taking important steps from the earliest days to combat the disease.
تاریخ انتشار اولیه: ۴ اردیبهشت ۱۳۹۹
تاریخ رصد: ۲ شهریور ۱۳۹۹